Literature DB >> 3654821

Determination of thymosin beta 4 in human blood cells and serum.

E Hannappel1, M van Kampen.   

Abstract

A simple one-step procedure for the determination of thymosin beta 4 in whole blood, various blood corpuscles, plasma and serum by reversed-phase high-performance liquid chromatography (HPLC) is described. The blood cells were isolated by a Ficoll density gradient technique. The isolated cells were lysed and deproteinized with perchloric acid in the presence of an internal standard. The supernatant solution was neutralized by potassium hydroxide solution and thymosin beta 4 was measured by HPLC without further manipulations. The following amounts (fg per cell) were determined: polymorphonuclear leukocytes (409), mononuclear leukocytes (267) and platelets (22.3). Erythrocytes contained no thymosin beta 4. The average concentration of thymosin beta 4 in an extract of whole blood was 16.3 micrograms/ml. The concentration in plasma was less than 1% of that value. However, if serum was prepared and not immediately removed from the clotted blood, the concentration of the peptide increased from 0.04 to 2.1 micrograms/ml within 24 h. The biological significance of the findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3654821     DOI: 10.1016/s0021-9673(01)85010-x

Source DB:  PubMed          Journal:  J Chromatogr


  27 in total

1.  The control of actin nucleotide exchange by thymosin beta 4 and profilin. A potential regulatory mechanism for actin polymerization in cells.

Authors:  P J Goldschmidt-Clermont; M I Furman; D Wachsstock; D Safer; V T Nachmias; T D Pollard
Journal:  Mol Biol Cell       Date:  1992-09       Impact factor: 4.138

2.  The interaction of actin with thymosin beta 4.

Authors:  D Safer
Journal:  J Muscle Res Cell Motil       Date:  1992-06       Impact factor: 2.698

3.  Evidence for the extranuclear localization of thymosins in thymus.

Authors:  O E Tsitsiloni; P P Yialouris; H Echner; W Voelter; A A Haritos
Journal:  Experientia       Date:  1992-04-15

4.  The complete sequences of trout (Salmo gairdneri) thymosin beta 11 and its homologue thymosin beta 12.

Authors:  P P Yialouris; B Coles; O Tsitsiloni; B Schmid; S Howell; A Aitken; W Voelter; A A Haritos
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

5.  Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway.

Authors:  Gabriel Sosne; Ping Qiu; Patricia L Christopherson; Michelle Kurpakus Wheater
Journal:  Exp Eye Res       Date:  2007-01-23       Impact factor: 3.467

6.  Distribution and biological activity ofβ-thymosins.

Authors:  M Mihelić; W Voelter
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

Review 7.  Thymosin β4 for the treatment of acute stroke: neurorestorative or neuroprotective?

Authors:  Daniel C Morris; Zheng G Zhang; Michael Chopp
Journal:  Expert Opin Biol Ther       Date:  2018-07       Impact factor: 4.388

8.  Prothymosin alpha is not a nuclear polypeptide.

Authors:  O E Tsitsiloni; P P Yialouris; K Sekeri-Pataryas; A A Haritos
Journal:  Experientia       Date:  1989-04-15

9.  Internetwork competition for monomers governs actin cytoskeleton organization.

Authors:  Cristian Suarez; David R Kovar
Journal:  Nat Rev Mol Cell Biol       Date:  2016-09-14       Impact factor: 94.444

10.  Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent.

Authors:  Gabriel Sosne; Ping Qiu; Michelle Kurpakus-Wheater
Journal:  Clin Ophthalmol       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.